Estradiol hemisuccinate

Estradiol hemisuccinate
Clinical data
Trade names	Eutocol
Identifiers
	IUPAC name 4-{[(17β)-3-Hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid;
CAS Number	7698-93-3;
PubChem CID	66440;
DrugBank	DB07891;
ChemSpider	59813;
UNII	VQV5064VG6;
Chemical and physical data
Formula	C22H28O5
Molar mass	372.46 g/mol
3D model (JSmol)	Interactive image;
	SMILES C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC(=O)O)O;
	InChI InChI=1S/C22H28O5/c1-22-11-10-16-15-5-3-14(23)12-13(15)2-4-17(16)18(22)6-7-19(22)27-21(26)9-8-20(24)25/h3,5,12,16-19,23H,2,4,6-11H2,1H3,(H,24,25)/t16-,17-,18+,19+,22+/m1/s1; Key:YJPIDPAGJSWWBE-FNIAAEIWSA-N;

Estradiol hemisuccinate (brand name Eutocol), or simply estradiol succinate, also known as estradiol 17β-hemisuccinate, is a semisynthetic, steroidal estrogen and an estrogen ester – specifically, the hemisuccinate ester of estradiol.^[1] It is used as a component of hormone replacement therapy for menopause.^[2] Like other estrogens, estradiol hemisuccinate has been found to have beneficial effects on the skin, with improvement of skin thickness observed.^[3]^[4]

References

↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 897. ISBN 978-1-4757-2085-3.
↑ Miranda A. Farage; Kenneth W. Miller; Howard I. Maibach (2 December 2009). Textbook of Aging Skin. Springer Science & Business Media. pp. 362–. ISBN 978-3-540-89655-5.
↑ Thompson, Zack; Maibach, Howard I. (2010). "Biological Effects of Estrogen on Skin": 361–367. doi:10.1007/978-3-540-89656-2_35.
↑ Maheux R, Naud F, Rioux M, Grenier R, Lemay A, Guy J, Langevin M (1994). "A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness". Am. J. Obstet. Gynecol. 170 (2): 642–9. PMID 8116726.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.